Víctor Pérez1, Matilde Elices2, Bibiana Prat3, Eduard Vieta4, Jordi Blanch5, Jordi Alonso6, Josep Pifarré7, Philippe Mortier8, Ana Isabel Cebrià9, Maria T Campillo10, Montserrat Vila-Abad10, Francesc Colom1, Montserrat Dolz11, Cristina Molina3, Diego J Palao12. 1. Institut de Neuropsiquiatria i Addicions, Hospital del Mar, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, Spain; Hospital del Mar Medical Research Institute, IMIM, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain. 2. Institut de Neuropsiquiatria i Addicions, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute, IMIM, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain. Electronic address: melices@imim.es. 3. Master Plan on Mental Health and Addictions, Ministry of Health, Catalan Government, Spain. 4. Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain; Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, Barcelona, Spain. 5. Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain; Master Plan on Mental Health and Addictions, Ministry of Health, Catalan Government, Spain; Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, Barcelona, Spain. 6. Hospital del Mar Medical Research Institute, IMIM, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Department of Health & Experimental Sciences, Pompeu Fabra University (UPF), Barcelona, Spain. 7. Department of Mental Health, Hospital Universitari de Santa Maria. SJD Terres de Lleida. IRBLleida, Spain. 8. Hospital del Mar Medical Research Institute, IMIM, Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain. 9. Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain; Department of Mental Health, Corporació Sanitaria Parc Taulí de Sabadell, Barcelona. 10. Institut de Neuropsiquiatria i Addicions, Hospital del Mar, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, Spain; Hospital del Mar Medical Research Institute, IMIM, Barcelona, Spain. 11. Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain; Hospital Sant Joan de Déu, Espluges de Llobregat, Barcelona, Spain; Children and Adolescent Mental Health Research Group, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain. 12. Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid, Spain; Department of Mental Health, Corporació Sanitaria Parc Taulí de Sabadell, Barcelona.
Abstract
BACKGROUND: Suicide prevention is an emerging priority for public health systems. Here, we present the Catalonia Suicide Risk Code (CSRC), a secondary suicide prevention program that provides a systematic approach to follow-up care for patients at risk. We describe the care pathway of the CSRC and characteristics of the patients enrolled in the program. METHODS: Observational study based on data extracted from the Catalan health care system between the years 2014 and 2019. The following patient-related data were obtained: sociodemographic and clinical characteristics, characteristics of suicidal behaviour, and pathway of care. RESULTS: A total of 12,596 individuals (64.1% women) were screened for suicide risk and 8,403 (66.7%) were subsequently enrolled in the CSRC. Adherence data show that most patients (81.9%) attended a face-to-face appointment and most (67.1%) were successfully contacted by telephone afterwards. Most face-to-face appointments were performed within 10 days of enrolment for adults and 72 h for minors. Psychiatric disorders were significant risk factors for both men and women. Females were significantly more likely to report stressful life events, while males were more likely to report social problems. Compared to men, women were more likely to use poisoning. LIMITATIONS: Adherence to the CSRC care pathway might reflect obstacles to its implementation. Due to the observational study design, it is not possible to determine the effectiveness of the CSRC to reduce suicide re-attempts. CONCLUSIONS: Although the CSRC successfully provided follow-up care for many individuals at high risk of suicide, greater adherence to the CSRC care pathway is needed.
BACKGROUND: Suicide prevention is an emerging priority for public health systems. Here, we present the Catalonia Suicide Risk Code (CSRC), a secondary suicide prevention program that provides a systematic approach to follow-up care for patients at risk. We describe the care pathway of the CSRC and characteristics of the patients enrolled in the program. METHODS: Observational study based on data extracted from the Catalan health care system between the years 2014 and 2019. The following patient-related data were obtained: sociodemographic and clinical characteristics, characteristics of suicidal behaviour, and pathway of care. RESULTS: A total of 12,596 individuals (64.1% women) were screened for suicide risk and 8,403 (66.7%) were subsequently enrolled in the CSRC. Adherence data show that most patients (81.9%) attended a face-to-face appointment and most (67.1%) were successfully contacted by telephone afterwards. Most face-to-face appointments were performed within 10 days of enrolment for adults and 72 h for minors. Psychiatric disorders were significant risk factors for both men and women. Females were significantly more likely to report stressful life events, while males were more likely to report social problems. Compared to men, women were more likely to use poisoning. LIMITATIONS: Adherence to the CSRC care pathway might reflect obstacles to its implementation. Due to the observational study design, it is not possible to determine the effectiveness of the CSRC to reduce suicide re-attempts. CONCLUSIONS: Although the CSRC successfully provided follow-up care for many individuals at high risk of suicide, greater adherence to the CSRC care pathway is needed.
Authors: Xavier Alvarez-Subiela; Carmina Castellano-Tejedor; Mireia Verge-Muñoz; Kike Esnaola-Letemendia; Diego Palao-Vidal; Francisco Villar-Cabeza Journal: Int J Environ Res Public Health Date: 2022-06-21 Impact factor: 4.614
Authors: V Pérez; M Elices; G Vilagut; E Vieta; J Blanch; E Laborda-Serrano; B Prat; F Colom; D Palao; J Alonso Journal: Eur Neuropsychopharmacol Date: 2021-11-19 Impact factor: 5.415